On (b)(6) 2015, a customer contacted biomérieux france subsidiary to report a false positive result obtained with vidas® brahms procalcitonin (pct) ref.30450 lot 1003549050 (expiration date 22-oct-2015).The patient was tested (b)(6) 2014 with vidas® brahms pct, lot 1003549050.The result was positive at 15.63 ng/ml indicating a high risk of severe sepsis and/or septic shock.Based on the sample result and patient's clinical status, the clinician performed a lumbar puncture to confirm or exclude meningitis infection.In conjunction with the lumbar puncture procedure, the clinician collected another sample (collected at 1:00pm) for testing; the result of this test was negative at 0.28 ng/ml.A second aliquot of the first sample was retested with vidas brahms pct and the result was negative (0.36 and 0.34 ng/ml).No further information has been provided regarding the clinical status of the patient or the reason to take the decision of performing the lumbar puncture.Internal biomérieux investigation has been initiated.As the sample for which the false positive result was reported is no longer available, the investigation will include a review of the batch file and complaint history records.This file will be updated as further information becomes available.
|